{
  "drug_name": "Doxycycline",
  "drug_id": "doxycycline",
  "generic_name": "doxycycline",
  "brand_names": [
    "Vibramycin",
    "Doryx",
    "Acticlate"
  ],
  "class": "Tetracycline Antibiotic",
  "version": "3.0.0",
  "last_updated": "2025-10-08",
  "routes": [
    "PO",
    "IV"
  ],
  "default_route": "PO",
  "contraindications": {
    "absolute": [
      "pregnancy",
      "children_<8_years",
      "tetracycline_allergy"
    ],
    "relative": [
      "esophageal_disease",
      "myasthenia_gravis"
    ],
    "note": "CONTRAINDICATED in pregnancy and children <8 years (tooth discoloration, bone growth effects)."
  },
  "allergy_considerations": {
    "pcn_allergy": {
      "safe": true,
      "contraindicated": false,
      "note": "Safe with PCN allergy. Excellent alternative for many PCN-allergic patients."
    },
    "severe_pcn_allergy": {
      "safe": true,
      "contraindicated": false,
      "note": "Safe alternative for severe PCN allergy (no cross-reactivity)"
    },
    "sulfa_allergy": {
      "safe": true,
      "note": "Safe with sulfa allergy"
    },
    "cephalosporin_allergy": {
      "safe": true,
      "note": "Safe with cephalosporin allergy"
    }
  },
  "pregnancy_category": "D",
  "pregnancy_safe": false,
  "pregnancy_notes": "CONTRAINDICATED in pregnancy (all trimesters). Causes tooth discoloration and inhibits bone growth in fetus.",
  "renal_adjustment": {
    "required": false,
    "note": "NO renal dose adjustment needed. Primarily fecal excretion. Safe in renal failure."
  },
  "dosing": {
    "by_indication": {
      "ssti_mrsa": {
        "dose": "100 mg PO",
        "frequency": "BID (q12h)",
        "duration": "7-10 days",
        "note": "First-line for MRSA skin infections (outpatient). Alternative to TMP/SMX.",
        "route": "PO",
        "loading_dose": null
      },
      "cap": {
        "dose": "100 mg PO",
        "frequency": "BID (q12h)",
        "duration": "5-7 days",
        "note": "For community-acquired pneumonia (atypical coverage)",
        "route": "PO"
      },
      "bite_wound": {
        "dose": "100 mg PO",
        "frequency": "BID (q12h)",
        "duration": "3-5 days",
        "note": "Alternative for bite wounds with PCN allergy (combine with metronidazole for anaerobes)",
        "route": "PO"
      },
      "tick_borne": {
        "dose": "100 mg PO",
        "frequency": "BID (q12h)",
        "duration": "10-21 days (depends on disease)",
        "note": "First-line for Rocky Mountain Spotted Fever, Lyme disease, ehrlichiosis, anaplasmosis",
        "route": "PO"
      },
      "lyme_disease": {
        "dose": "100 mg PO",
        "frequency": "BID (q12h)",
        "duration": "10-21 days",
        "note": "First-line for early Lyme disease",
        "route": "PO"
      },
      "pelvic_inflammatory_disease": {
        "dose": "100 mg PO",
        "frequency": "BID (q12h)",
        "duration": "14 days",
        "note": "Outpatient PID regimen (with ceftriaxone 500 mg IM \u00d7 1)",
        "route": "PO"
      },
      "chlamydia": {
        "dose": "100 mg PO",
        "frequency": "BID (q12h)",
        "duration": "7 days",
        "note": "First-line for Chlamydia trachomatis (alternative: azithromycin 1 g \u00d7 1)",
        "route": "PO"
      },
      "atypical_pneumonia": {
        "dose": "100 mg PO",
        "frequency": "BID (q12h)",
        "duration": "7-10 days",
        "note": "For Mycoplasma, Chlamydia pneumoniae",
        "route": "PO"
      },
      "malaria_prophylaxis": {
        "dose": "100 mg PO",
        "frequency": "daily",
        "duration": "Start 1-2 days before travel, continue 4 weeks after",
        "note": "Malaria prophylaxis (endemic areas)",
        "route": "PO"
      },
      "ssti": {
        "dose": "100 mg PO",
        "frequency": "BID",
        "duration": "7-10 days",
        "route": "PO",
        "note": "Excellent for community-acquired MRSA SSTI"
      }
    },
    "pediatric": {
      "note": "CONTRAINDICATED in children <8 years (tooth discoloration). If >8 years and >45 kg: adult dose."
    }
  },
  "monitoring": {
    "required": [
      "clinical response"
    ],
    "optional": [
      "liver function tests (if prolonged therapy)"
    ]
  },
  "drug_interactions": {
    "major": [
      "antacids (decrease absorption)",
      "calcium/iron/zinc supplements (chelation - decrease absorption)",
      "warfarin (increases INR)"
    ],
    "moderate": [
      "oral contraceptives (may decrease effectiveness)",
      "penicillins (antagonism)"
    ]
  },
  "adverse_effects": {
    "common": [
      "nausea (COMMON - take with food)",
      "photosensitivity (WARN patients - use sunscreen)",
      "esophagitis (take with water, remain upright)"
    ],
    "serious": [
      "severe photosensitivity reactions",
      "esophageal ulceration",
      "hepatotoxicity (rare)",
      "intracranial hypertension (pseudotumor cerebri - rare)"
    ],
    "rare": [
      "C. difficile colitis",
      "tooth discoloration (if used <8 years)"
    ]
  },
  "spectrum": {
    "gram_positive": "Good (MSSA, some MRSA - check local susceptibility)",
    "gram_negative": "Moderate",
    "anaerobes": "Limited (not reliable)",
    "atypicals": "Excellent (Mycoplasma, Chlamydia, Rickettsia, Ehrlichia, Borrelia)"
  },
  "notes": [
    "\u26a0\ufe0f CONTRAINDICATED in pregnancy and children <8 years",
    "First-line for MRSA SSTI (alternative to TMP/SMX)",
    "First-line for tick-borne diseases (Lyme, RMSF, ehrlichiosis)",
    "Excellent atypical coverage (Mycoplasma, Chlamydia)",
    "Safe with PCN/sulfa allergies",
    "NO renal dose adjustment needed (safe in renal failure)",
    "\u26a0\ufe0f PHOTOSENSITIVITY - warn patients to use sunscreen",
    "Take with food to reduce nausea",
    "Take with full glass of water, remain upright 30 min (prevent esophagitis)",
    "AVOID: antacids, calcium, iron, zinc within 2 hours (chelation)",
    "May reduce oral contraceptive effectiveness (use backup method)",
    "DO NOT combine with penicillins (antagonism)"
  ],
  "evidence": [
    "IDSA SSTI Guidelines 2014 - first-line for CA-MRSA",
    "IDSA Lyme Disease Guidelines 2020",
    "CDC Tick-Borne Disease Guidelines"
  ]
}